Navigation Links
Sangamo BioSciences Announces Presentation at the Future Leaders in the Biotech Industry Conference
Date:4/12/2012

RICHMOND, Calif., April 12, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and an overview of the company's business strategy at 1:30 pm ET on Friday, April 20, 2012, at the Future Leaders in the Biotech Industry Conference which will be held in New York City.

The presentation will be webcast live and may be accessed via a link on the Sangamo BioSciences website in the Investor Relations section http://investor.sangamo.com/index.cfm under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo

Sangamo BioSciences, Inc. is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and genome editing. It has ongoing Phase 2 and Phase 1/2 clinical trials to evaluate the safety and efficacy of a novel ZFP Therapeutic® for the treatment of HIV/AIDS. Sangamo's other therapeutic programs are focused on monogenic diseases, including hemophilia and hemoglobinopathies such as sickle cell anemia and beta-thalassemia, and a program in Parkinson's disease. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs).  Engineering of ZFPs that recognize a specific DNA sequence enables the creation of sequence-specific ZFP Nucleases (ZFNs) for gene modification and ZFP transcription factors (ZFP TFs) that can control gene expression and, consequently, cell function.  Sangamo has entered into a strategic collaboration with Shire to develop therapeutics for hemophilia and other monogenic diseases and has established strategic partnerships with companies in non-therapeutic applications of its technology including Dow AgroSciences and Sigma-Aldrich Corporation. For more information about Sangamo, visit the company's website at www.sangamo.com

ZFP Therapeutic® is a registered trademark of Sangamo BioSciences, Inc.

 


'/>"/>
SOURCE Sangamo BioSciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sangamo BioSciences Announces Presentation at the Sixth Annual JMP Securities Healthcare Conference
2. Sangamo BioSciences and Collaborators Present Data Showcasing Broad Applications of ZFP Therapeutics®
3. Sangamo BioSciences Announces Presentation at the Cowen and Company 31st Annual Health Care Conference
4. Sangamo BioSciences Announces Presentation of Positive Clinical Data From Novel ZFN Therapeutic Approach for the Treatment of HIV/AIDs at Conference for Retroviral and Opportunistic Infections
5. Sangamo BioSciences Announces Presentation at the 13th Annual BIO CEO & Investor Conference
6. Sangamo BioSciences Announces Presentation of Phase 2 Data in Amyotrophic Lateral Sclerosis (ALS) at Society for Neuroscience Meeting
7. Sangamo BioSciences Announces Presentation at Lazard Capital Markets Healthcare Conference
8. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant Human Stem Cells
9. Sangamo BioSciences Receives Michael J. Fox Foundation Funding to Develop Novel Drug for the Treatment of Parkinsons Disease
10. Sangamo BioSciences Announces First Quarter 2010 Conference Call and Webcast
11. Sangamo BioSciences Announces Fourth Quarter and Full Year 2009 Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2020)... , ... March 27, 2020 , ... ... Isagenix International has named Gary Gallant as its permanent CIO. In this ... company’s technology vision, ensuring Isagenix can provide a smooth shopping experience for customers ...
(Date:3/27/2020)... ... March 27, 2020 , ... ... platform based on students' holistic portfolios, revealed that college-bound young adults are reconsidering ... is creating huge new barriers to high school senior’s path to college and ...
(Date:3/22/2020)... ... March 21, 2020 , ... As the spread of ... Department of Thoracic Medicine and Surgery, and the Temple Lung Center have taken ... symptom tracking platform and triage/care coordination services. Temple is now enrolling patients, faculty, ...
Breaking Medicine Technology:
(Date:3/27/2020)... MARY, Fla. (PRWEB) , ... March 27, 2020 , ... ... three-month online educational health conference for people with asthma, their families and caregivers living ... a day between March 27, 2020 and June 30, 2020, and will focus on ...
(Date:3/22/2020)... JACKSONVILLE, Fla. (PRWEB) , ... March 21, 2020 ... ... remote patient communication, announces easy-to-implement solutions that hospitals, medical organizations, and health centers ... healthcare sector adapts to the coronavirus pandemic, many medical professionals are working around ...
(Date:3/20/2020)... ... March 20, 2020 , ... ... an interdisciplinary team of researchers in machine learning, bioinformatics, immunology, virology and vaccine ... and future outbreaks. , "The COVID-19 crisis gives us an opportunity and a ...
(Date:3/19/2020)... (PRWEB) , ... March 19, 2020 , ... As confirmed ... to support America’s response efforts. , “As a global humanitarian organization, Project HOPE’s mandate ... massive right here at home,” said Rabih Torbay, President and CEO of Project HOPE. ...
(Date:3/16/2020)... ... March 16, 2020 , ... To avoid ... Delta Human Services Authority is implementing several new universal health and safety measures ... clients and staff," said Dr. Monteic A. Sizer, executive director of Northeast Delta. ...
Breaking Medicine News(10 mins):